The YCLONE brand, founded in 2012 (Germany), from 24 sister brands and 2214 competing brands. The YCLONE brand is owned by MORPHOSYS AG, a company listed in Francfort. Its International Securities Identification Number (ISIN) is DE0006632003. YCLONE belongs to the Biotechnology business sector.

YCLONE is a brand of MORPHOSYS AG (MOR) Share price

International deposit : 2012 Business sector Biotechnology

Share price and profitability of the share MORPHOSYS AG (YCLONE)

Buy MORPHOSYS AG share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 67.45

Portfolio valuation
MORPHOSYS AG (YCLONE) over 5 years* EUR 52.90

Stock market history MORPHOSYS AG (YCLONE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
MORPHOSYS AG

MorphoSys
MorphoSys
See more brands of MORPHOSYS AG

Rival brands
YCLONE

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS